Efficacy and resistance of recently developed non-nucleoside reverse transcriptase inhibitors for HIV-1

about

Efficacy and resistance of recently developed non-nucleoside reverse transcriptase inhibitors for HIV-1

Item

http://www.wikidata.org/entity/Q58388963

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2009

@uk

name

Efficacy and resistance of rec ...... scriptase inhibitors for HIV-1

@en

Efficacy and resistance of rec ...... scriptase inhibitors for HIV-1

@nl

type

Item

label

Efficacy and resistance of rec ...... scriptase inhibitors for HIV-1

@en

Efficacy and resistance of rec ...... scriptase inhibitors for HIV-1

@nl

prefLabel

Efficacy and resistance of rec ...... scriptase inhibitors for HIV-1

@en

Efficacy and resistance of rec ...... scriptase inhibitors for HIV-1

@nl

P1476

Efficacy and resistance of rec ...... scriptase inhibitors for HIV-1

@en

P2093

Roberto Rossotti

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors.

Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analyses

Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase

High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations.

Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptase

Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant viruses

Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors

Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance

Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

P304

63-77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/17584310.3.1.63

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stefano Rusconi

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime